Incidence and survival of chronic myelomonocytic leukemia in Girona (Spain): a population-based study, 1993-2007.
Chronic myelomonocytic leukemia is a very rare blood cancer observed mostly in the elderly. Here we report the incidence trends and survival of patients with chronic myelomonocytic leukemia over a 15-year period (1993-2007). Cases were provided by the population-based Girona Cancer Registry. The crude incidence rate was 0.72/100,000 inhabitants/year. No statistically significant increase in trends was detected over the 15 years. Median overall survival was 28 months although survival markedly decreased with advancing age. The 5-years observed and relative survivals were 20% and 29%, respectively. This is the first population-based study that reports the incidence and survival of chronic myelomonocytic leukemia in Spain.
Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health, Autonomous Government of Catalonia, Catalan Institute of Oncology, Girona Biomedical Research Institute (IdiBGi), Girona, Spain. gemma.osca.gelis@gmail.com
Gemma
G
Osca-Gelis
Montserrat
M
Puig-Vives
Marc
M
Saez
David
D
Gallardo
Francesc
F
Solé
Rafael
R
Marcos-Gragera
D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D015994:Incidence; D015477:Leukemia, Myelomonocytic, Chronic / Q000453:epidemiology* / Q000401:mortality*; D008297:Male; D008875:Middle Aged; D012042:Registries; D013030:Spain / Q000453:epidemiology; D015996:Survival Rate; D013997:Time Factors